JDRF T1D Fund

About

The T1D Fund is a mission-driven venture philanthropy fund that co-invests globally from discovery through clinical-stage development in differentiated therapies and technologies with the potential to treat, prevent, or cure type 1 diabetes.

Sectors

• Life Sciences
• Healthtech / Digital Health

Notable investments

• Aera Therapeutics
• Adaxion Therapeutics
• Aspect Biosystems
• Aurimi Therapeutics
• Bigfoot Biomedical
• Biolinq
• Capillary Biomedical
• COUR Pharmaceuticals
• Diasome Pharmaceuticals
• DiogenX

Investors

• Sylvia Tobé, Ph.D.Managing Director→
• Lucio Iannone, Ph.D.Managing Director→
• Daniel Flicker, Ph.D.Principal→
• Peyman HosseinchiSenior Associate→
• Valerie Su, Ph.D.Associate→
• Morgan Janes, Ph.D.Associate→
• Yash MalliwalSenior Analyst→

How to reach them

https://t1dfund.org/contact-us/